{"id":"https://openalex.org/W3199014335","doi":"https://doi.org/10.1038/s42003-021-02616-x","title":"Modelling human liver fibrosis in the context of non-alcoholic steatohepatitis using a microphysiological system","display_name":"Modelling human liver fibrosis in the context of non-alcoholic steatohepatitis using a microphysiological system","alternate_titles":[],"publication_year":2021,"publication_date":"2021-09-15","ids":{"openalex":"https://openalex.org/W3199014335","doi":"https://doi.org/10.1038/s42003-021-02616-x","mag":"3199014335","pmid":"https://pubmed.ncbi.nlm.nih.gov/34526653","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/8443589"},"language":"en","primary_location":{"id":"doi:10.1038/s42003-021-02616-x","doi":"https://doi.org/10.1038/s42003-021-02616-x","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s42003-021-02616-x","pdf_url":"https://www.nature.com/articles/s42003-021-02616-x.pdf","source":{"id":"https://openalex.org/S4210225776","display_name":"Communications Biology","issn_l":"2399-3642","issn":["2399-3642"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-2","medline","norway-1","oarl","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Communications Biology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W3199014335"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.nature.com/articles/s42003-021-02616-x.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5074477230","display_name":"Tomasz M. Kostrzewski","orcid":"https://orcid.org/0000-0001-6309-628X","observed_orcids":["https://orcid.org/0000-0001-6309-628X"]},"institutions":[{"id":"https://openalex.org/I4210128429","display_name":"CN Bio Innovations (United Kingdom)","ror":"https://ror.org/03gy09487","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210128429"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Tomasz Kostrzewski","raw_affiliation_strings":["CN Bio Innovations Ltd, Cambridge, UK. tomasz.kostrzewski@cn-bio.com","CN Bio Innovations Ltd, Cambridge, UK"],"raw_orcid":"https://orcid.org/0000-0001-6309-628X","affiliations":[{"raw_affiliation_string":"CN Bio Innovations Ltd, Cambridge, UK. tomasz.kostrzewski@cn-bio.com","institution_ids":["https://openalex.org/I4210128429"]},{"raw_affiliation_string":"CN Bio Innovations Ltd, Cambridge, UK","institution_ids":["https://openalex.org/I4210128429"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008531325","display_name":"Sophie Snow","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210128429","display_name":"CN Bio Innovations (United Kingdom)","ror":"https://ror.org/03gy09487","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210128429"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sophie Snow","raw_affiliation_strings":["CN Bio Innovations Ltd, Cambridge, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CN Bio Innovations Ltd, Cambridge, UK","institution_ids":["https://openalex.org/I4210128429"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000085280","display_name":"Anya Lindstr\u00f6m Battle","orcid":"https://orcid.org/0000-0001-6356-4688","observed_orcids":["https://orcid.org/0000-0001-6356-4688"]},"institutions":[{"id":"https://openalex.org/I4210128429","display_name":"CN Bio Innovations (United Kingdom)","ror":"https://ror.org/03gy09487","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210128429"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Anya Lindstr\u00f6m Battle","raw_affiliation_strings":["CN Bio Innovations Ltd, Cambridge, UK"],"raw_orcid":"https://orcid.org/0000-0001-6356-4688","affiliations":[{"raw_affiliation_string":"CN Bio Innovations Ltd, Cambridge, UK","institution_ids":["https://openalex.org/I4210128429"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067000367","display_name":"Samantha E. Peel","orcid":"https://orcid.org/0000-0001-9850-1409","observed_orcids":["https://orcid.org/0000-0001-9850-1409"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Samantha Peel","raw_affiliation_strings":["Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Cambridge, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Cambridge, UK","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103545247","display_name":"Zahida Ahmad","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Zahida Ahmad","raw_affiliation_strings":["Translational Biomarkers and Bioanalysis, Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Translational Biomarkers and Bioanalysis, Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010895879","display_name":"Jayati Basak","orcid":"https://orcid.org/0009-0006-4295-7224","observed_orcids":["https://orcid.org/0009-0006-4295-7224"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jayati Basak","raw_affiliation_strings":["Translational Biomarkers and Bioanalysis, Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Translational Biomarkers and Bioanalysis, Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024753140","display_name":"Manasa Surakala","orcid":"https://orcid.org/0000-0002-6158-3460","observed_orcids":["https://orcid.org/0000-0002-6158-3460"]},"institutions":[{"id":"https://openalex.org/I4210127920","display_name":"AstraZeneca (India)","ror":"https://ror.org/03ma9wk70","country_code":"IN","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210127920"]}],"countries":["IN"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Manasa Surakala","raw_affiliation_strings":["R&D IT, AstraZeneca, Chennai, India"],"raw_orcid":"https://orcid.org/0000-0002-6158-3460","affiliations":[{"raw_affiliation_string":"R&D IT, AstraZeneca, Chennai, India","institution_ids":["https://openalex.org/I4210127920"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026111313","display_name":"Aur\u00e9lie Bornot","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Aurelie Bornot","raw_affiliation_strings":["Quantitative Biology and Data Science, Discovery Sciences, R&D, AstraZeneca, Cambridge, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Quantitative Biology and Data Science, Discovery Sciences, R&D, AstraZeneca, Cambridge, UK","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Julia Lindgren","orcid":"https://orcid.org/0000-0002-3566-2069","observed_orcids":["https://orcid.org/0000-0002-3566-2069"]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Julia Lindgren","raw_affiliation_strings":["Translational Genomics, Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Gothenburg, Sweden"],"raw_orcid":"https://orcid.org/0000-0002-3566-2069","affiliations":[{"raw_affiliation_string":"Translational Genomics, Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Gothenburg, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032141958","display_name":"Maria Ryaboshapkina","orcid":"https://orcid.org/0000-0003-1385-8869","observed_orcids":["https://orcid.org/0000-0003-1385-8869"]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Maria Ryaboshapkina","raw_affiliation_strings":["Translational Science and Experimental Medicine, Research and Early Development Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden"],"raw_orcid":"https://orcid.org/0000-0003-1385-8869","affiliations":[{"raw_affiliation_string":"Translational Science and Experimental Medicine, Research and Early Development Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065134492","display_name":"Maryam Clausen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Maryam Clausen","raw_affiliation_strings":["Translational Genomics, Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Gothenburg, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Translational Genomics, Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Gothenburg, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040428765","display_name":"Daniel Lind\u00e9n","orcid":"https://orcid.org/0000-0003-4158-8018","observed_orcids":["https://orcid.org/0000-0003-4158-8018"]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]},{"id":"https://openalex.org/I881427289","display_name":"University of Gothenburg","ror":"https://ror.org/01tm6cn81","country_code":"SE","type":"education","lineage":["https://openalex.org/I881427289"]}],"countries":["SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Daniel Lind\u00e9n","raw_affiliation_strings":["Bioscience Metabolism, Research and Early Development Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden","Division of Endocrinology, Department of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bioscience Metabolism, Research and Early Development Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden","institution_ids":["https://openalex.org/I4210143795"]},{"raw_affiliation_string":"Division of Endocrinology, Department of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden","institution_ids":["https://openalex.org/I881427289"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070536964","display_name":"Christian Maa\u00df","orcid":"https://orcid.org/0000-0001-7618-0421","observed_orcids":["https://orcid.org/0000-0001-7618-0421"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Christian Maass","raw_affiliation_strings":["Certara, Quantitative Systems Pharmacology Unit, Sheffield, UK","esqLABS GmbH, Saterland, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Certara, Quantitative Systems Pharmacology Unit, Sheffield, UK","institution_ids":[]},{"raw_affiliation_string":"esqLABS GmbH, Saterland, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051296306","display_name":"Lucy-May Young","orcid":"https://orcid.org/0000-0003-2731-1514","observed_orcids":["https://orcid.org/0000-0003-2731-1514"]},"institutions":[{"id":"https://openalex.org/I4210128429","display_name":"CN Bio Innovations (United Kingdom)","ror":"https://ror.org/03gy09487","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210128429"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Lucy May Young","raw_affiliation_strings":["CN Bio Innovations Ltd, Cambridge, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CN Bio Innovations Ltd, Cambridge, UK","institution_ids":["https://openalex.org/I4210128429"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039651767","display_name":"Adam\u00a0M. Corrigan","orcid":"https://orcid.org/0000-0001-5142-6579","observed_orcids":["https://orcid.org/0000-0001-5142-6579"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Adam Corrigan","raw_affiliation_strings":["Quantitative Biology and Data Science, Discovery Sciences, R&D, AstraZeneca, Cambridge, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Quantitative Biology and Data Science, Discovery Sciences, R&D, AstraZeneca, Cambridge, UK","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000090567","display_name":"Lorna C. Ewart","orcid":"https://orcid.org/0000-0002-8258-7460","observed_orcids":["https://orcid.org/0000-0002-8258-7460"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Lorna Ewart","raw_affiliation_strings":["Translational Biomarkers and Bioanalysis, Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK"],"raw_orcid":"https://orcid.org/0000-0002-8258-7460","affiliations":[{"raw_affiliation_string":"Translational Biomarkers and Bioanalysis, Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5101664027","display_name":"David J. Hughes","orcid":"https://orcid.org/0000-0002-7811-7263","observed_orcids":["https://orcid.org/0000-0002-7811-7263"]},"institutions":[{"id":"https://openalex.org/I4210128429","display_name":"CN Bio Innovations (United Kingdom)","ror":"https://ror.org/03gy09487","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210128429"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"David Hughes","raw_affiliation_strings":["CN Bio Innovations Ltd, Cambridge, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CN Bio Innovations Ltd, Cambridge, UK","institution_ids":["https://openalex.org/I4210128429"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5074477230"],"corresponding_institution_ids":["https://openalex.org/I4210128429"],"apc_list":{"value":3290,"currency":"USD","value_usd":3290},"apc_paid":{"value":3290,"currency":"USD","value_usd":3290},"fwci":3.7199,"has_fulltext":true,"cited_by_count":59,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.94817143,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":100},"biblio":{"volume":"4","issue":"1","first_page":"1080","last_page":"1080"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10351","display_name":"Liver Disease Diagnosis and Treatment","score":0.9452999830245972,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10351","display_name":"Liver Disease Diagnosis and Treatment","score":0.9452999830245972,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10966","display_name":"Liver physiology and pathology","score":0.047200001776218414,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11465","display_name":"Drug-Induced Hepatotoxicity and Protection","score":0.001500000013038516,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/non-alcoholic-steatohepatitis","display_name":"nonalcoholic steatohepatitis","score":0.996999979019165},{"id":"https://openalex.org/keywords/liver-fibrosis","display_name":"liver fibrosis","score":0.9990000128746033},{"id":"https://openalex.org/keywords/microphysiological-systems","display_name":"microphysiological systems","score":0.949999988079071},{"id":"https://openalex.org/keywords/in-vitro-disease-model","display_name":"in vitro disease model","score":0.7049999833106995},{"id":"https://openalex.org/keywords/co-culture","display_name":"co-culture","score":0.8500000238418579},{"id":"https://openalex.org/keywords/transcriptomics","display_name":"transcriptomics","score":0.7480000257492065},{"id":"https://openalex.org/keywords/inflammation","display_name":"inflammation","score":0.7870000004768372},{"id":"https://openalex.org/keywords/transforming-growth-factor-beta","display_name":"TGF-beta","score":0.8149999976158142},{"id":"https://openalex.org/keywords/lipopolysaccharide","display_name":"lipopolysaccharide","score":0.9810000061988831},{"id":"https://openalex.org/keywords/dietary-intervention","display_name":"dietary intervention","score":0.5849999785423279},{"id":"https://openalex.org/keywords/obeticholic-acid","display_name":"obeticholic acid","score":0.9990000128746033},{"id":"https://openalex.org/keywords/elafibranor","display_name":"elafibranor","score":0.9900000095367432},{"id":"https://openalex.org/keywords/fibrosis-markers","display_name":"fibrosis biomarkers","score":0.5180000066757202}],"concepts":[{"id":"https://openalex.org/C2779478299","wikidata":"https://www.wikidata.org/wiki/Q2335423","display_name":"Steatohepatitis","level":4,"score":0.9277441501617432},{"id":"https://openalex.org/C2780559512","wikidata":"https://www.wikidata.org/wiki/Q605709","display_name":"Fibrosis","level":2,"score":0.7637213468551636},{"id":"https://openalex.org/C2778772119","wikidata":"https://www.wikidata.org/wiki/Q6058862","display_name":"Fatty liver","level":3,"score":0.6412200927734375},{"id":"https://openalex.org/C2777067796","wikidata":"https://www.wikidata.org/wiki/Q15708271","display_name":"Obeticholic acid","level":4,"score":0.5834931135177612},{"id":"https://openalex.org/C2779343474","wikidata":"https://www.wikidata.org/wiki/Q3109175","display_name":"Context (archaeology)","level":2,"score":0.5006105899810791},{"id":"https://openalex.org/C2776175330","wikidata":"https://www.wikidata.org/wiki/Q1365091","display_name":"Steatosis","level":2,"score":0.47475817799568176},{"id":"https://openalex.org/C2779102576","wikidata":"https://www.wikidata.org/wiki/Q5113984","display_name":"Chronic liver disease","level":3,"score":0.46976304054260254},{"id":"https://openalex.org/C2777075537","wikidata":"https://www.wikidata.org/wiki/Q929737","display_name":"Liver disease","level":2,"score":0.4365420639514923},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.42967426776885986},{"id":"https://openalex.org/C164027704","wikidata":"https://www.wikidata.org/wiki/Q3491837","display_name":"Proinflammatory cytokine","level":3,"score":0.4238205850124359},{"id":"https://openalex.org/C127716648","wikidata":"https://www.wikidata.org/wiki/Q104053","display_name":"Phenotype","level":3,"score":0.4149530231952667},{"id":"https://openalex.org/C162317418","wikidata":"https://www.wikidata.org/wiki/Q252857","display_name":"Transcriptome","level":4,"score":0.4135435223579407},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.40766820311546326},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.38539230823516846},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.35471242666244507},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.303329199552536},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.2949214577674866},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.26907476782798767},{"id":"https://openalex.org/C2777214474","wikidata":"https://www.wikidata.org/wiki/Q147778","display_name":"Cirrhosis","level":2,"score":0.17299357056617737},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.07738974690437317},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.07210472226142883},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008103","descriptor_name":"Liver Cirrhosis","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D065626","descriptor_name":"Non-alcoholic Fatty Liver Disease","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":true}],"locations_count":5,"locations":[{"id":"doi:10.1038/s42003-021-02616-x","doi":"https://doi.org/10.1038/s42003-021-02616-x","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s42003-021-02616-x","pdf_url":"https://www.nature.com/articles/s42003-021-02616-x.pdf","source":{"id":"https://openalex.org/S4210225776","display_name":"Communications Biology","issn_l":"2399-3642","issn":["2399-3642"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-2","medline","norway-1","oarl","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Communications Biology","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:7379961","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC8443589","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:8443589","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8443589/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Commun Biol","raw_type":"Text"},{"id":"pmid:34526653","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/34526653","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Communications biology","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:2fe033487d4045ff86e6fb36c7f3e8b7","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/2fe033487d4045ff86e6fb36c7f3e8b7","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Communications Biology, Vol 4, Iss 1, Pp 1-15 (2021)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1038/s42003-021-02616-x","doi":"https://doi.org/10.1038/s42003-021-02616-x","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s42003-021-02616-x","pdf_url":"https://www.nature.com/articles/s42003-021-02616-x.pdf","source":{"id":"https://openalex.org/S4210225776","display_name":"Communications Biology","issn_l":"2399-3642","issn":["2399-3642"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-2","medline","norway-1","oarl","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Communications Biology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G3741699507","display_name":null,"funder_award_id":"Ref: 103598","funder_id":"https://openalex.org/F4320335087","funder_display_name":"Innovate UK"}],"funders":[{"id":"https://openalex.org/F4320335087","display_name":"Innovate UK","ror":"https://ror.org/05ar5fy68"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3199014335.pdf","grobid_xml":"https://content.openalex.org/works/W3199014335.grobid-xml"},"referenced_works_count":73,"referenced_works":["https://openalex.org/W232770196","https://openalex.org/W794483546","https://openalex.org/W1871647034","https://openalex.org/W1923904225","https://openalex.org/W1964572117","https://openalex.org/W1968628675","https://openalex.org/W1969295126","https://openalex.org/W1969807612","https://openalex.org/W1985592156","https://openalex.org/W1985859986","https://openalex.org/W1994834284","https://openalex.org/W2030666214","https://openalex.org/W2033474014","https://openalex.org/W2036924431","https://openalex.org/W2042694297","https://openalex.org/W2070050178","https://openalex.org/W2092700213","https://openalex.org/W2102278945","https://openalex.org/W2103703914","https://openalex.org/W2106768039","https://openalex.org/W2111288662","https://openalex.org/W2137516998","https://openalex.org/W2141179727","https://openalex.org/W2154731971","https://openalex.org/W2179438025","https://openalex.org/W2182670456","https://openalex.org/W2197124664","https://openalex.org/W2205982384","https://openalex.org/W2210672989","https://openalex.org/W2253420963","https://openalex.org/W2278937442","https://openalex.org/W2432250222","https://openalex.org/W2507554828","https://openalex.org/W2529961457","https://openalex.org/W2535490199","https://openalex.org/W2536520632","https://openalex.org/W2540412673","https://openalex.org/W2560504947","https://openalex.org/W2562967659","https://openalex.org/W2572737231","https://openalex.org/W2580009538","https://openalex.org/W2757404954","https://openalex.org/W2760380198","https://openalex.org/W2767233119","https://openalex.org/W2782050066","https://openalex.org/W2782129578","https://openalex.org/W2786205206","https://openalex.org/W2791607331","https://openalex.org/W2805548573","https://openalex.org/W2810423511","https://openalex.org/W2810800223","https://openalex.org/W2890309511","https://openalex.org/W2896985838","https://openalex.org/W2899389750","https://openalex.org/W2908632821","https://openalex.org/W2916828510","https://openalex.org/W2935565749","https://openalex.org/W2941033601","https://openalex.org/W2948100663","https://openalex.org/W2952849701","https://openalex.org/W2955615964","https://openalex.org/W2958296451","https://openalex.org/W2966886256","https://openalex.org/W2970070032","https://openalex.org/W2972557657","https://openalex.org/W2984745750","https://openalex.org/W2993083975","https://openalex.org/W3000479870","https://openalex.org/W3010755255","https://openalex.org/W3016840650","https://openalex.org/W3023564878","https://openalex.org/W3027189358","https://openalex.org/W3110917833"],"related_works":["https://openalex.org/W2984745750","https://openalex.org/W2560504947","https://openalex.org/W3205378558","https://openalex.org/W3000367822","https://openalex.org/W3135645602","https://openalex.org/W3040432147","https://openalex.org/W2972750724","https://openalex.org/W3016840650","https://openalex.org/W3042017400","https://openalex.org/W4297513227"],"abstract_inverted_index":{"Non-alcoholic":[0],"steatohepatitis":[1],"(NASH)":[2],"is":[3,27],"a":[4,28,64,75,101,135,197],"common":[5],"form":[6],"of":[7,16,45,66,77,93,117,128,141,156,184],"chronic":[8],"liver":[9,24,41,69],"disease":[10,48,195],"characterised":[11,97],"by":[12],"lipid":[13],"accumulation,":[14],"infiltration":[15],"immune":[17],"cells,":[18,70],"hepatocellular":[19],"ballooning,":[20],"collagen":[21],"deposition":[22],"and":[23,43,90,98,131,144,166],"fibrosis.":[25],"There":[26],"high":[29],"unmet":[30],"need":[31],"to":[32,105,122,162,180,192],"develop":[33],"treatments":[34],"for":[35],"NASH.":[36],"We":[37],"have":[38],"investigated":[39],"how":[40,172],"fibrosis":[42,167,199],"features":[44],"advanced":[46,111,194],"clinical":[47,112,185],"can":[49,177],"be":[50,178],"modelled":[51],"using":[52,100],"an":[53],"in":[54,74,148],"vitro":[55],"microphysiological":[56],"system":[57,102],"(MPS).":[58],"The":[59,87,114,139],"NASH":[60,175,186],"MPS":[61,174],"model":[62,95,119,133,176,181,193],"comprises":[63],"co-culture":[65],"primary":[67],"human":[68],"which":[71],"were":[72,146],"cultured":[73],"variety":[76],"conditions":[78,107],"including+/-":[79],"excess":[80],"sugar,":[81],"fat,":[82],"exogenous":[83],"TGF\u03b2":[84],"or":[85],"LPS.":[86],"transcriptomic,":[88],"inflammatory":[89,165],"fibrotic":[91,137],"phenotype":[92],"the":[94,118,126,132,149,154,173],"was":[96,120],"compared":[99],"biology":[103],"approach":[104],"identify":[106],"that":[108],"mimic":[109],"more":[110],"disease.":[113],"transcriptomic":[115],"profile":[116,127],"shown":[121],"closely":[123],"correlate":[124],"with":[125,159,196],"patient":[129],"samples":[130],"displayed":[134],"quantifiable":[136,198],"phenotype.":[138,200],"effects":[140,155],"Obeticholic":[142],"acid":[143],"Elafibranor,":[145],"evaluated":[147],"model,":[150],"as":[151,153],"wells":[152],"dietary":[157],"intervention,":[158],"all":[160],"able":[161],"significantly":[163],"reduce":[164],"markers.":[168],"Overall,":[169],"we":[170],"demonstrate":[171,189],"used":[179],"different":[182],"aspects":[183],"but":[187],"importantly":[188],"its":[190],"ability":[191]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W3199014335","counts_by_year":[{"year":2026,"cited_by_count":15},{"year":2025,"cited_by_count":8},{"year":2024,"cited_by_count":18},{"year":2023,"cited_by_count":9},{"year":2022,"cited_by_count":8},{"year":2021,"cited_by_count":1}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2021-09-27T00:00:00"}
